42 studies found for:    Bell's Palsy
Show Display Options
Rank Status Study
21 Completed Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age
Condition: Observation Safety
Intervention:
22 Completed Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801
Condition: Prophylaxis of Ross River Virus Infection
Intervention: Biological: Ross River Virus (RRV) Vaccine
23 Recruiting Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty
Condition: Facial Paresis
Intervention: Drug: injection of 1% lidocaine, 2mL for facial nerve block
24 Completed Ultrasound Evaluation of Tongue Movements in Speech and Swallowing
Conditions: Otorhinolaryngologic Disease;   Otorhinolaryngologic Neoplasm;   Pharyngeal Neoplasm;   Polymyositis;   Speech Disorder
Intervention:
25 Recruiting Quantification, Analysis and Simulation of Facial Mimics Movements
Condition: Mimic Facial Muscles
Intervention: Other: Magnetic Resonance Imaging (MRI), Surface scan, Motion capture, Digital Image Correlation
26 Completed Clinical Research Core Dental Screening Protocol
Condition: Oral Mucosal Disease
Intervention:
27 Withdrawn Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled Study
Condition: Nontuberculous Mycobacterial Lymphadenitis.
Intervention: Drug: Methylprednisoline
28 Recruiting R. I. S. POS. T. A
Conditions: Vacuum Extraction; Failure, Affecting Fetus or Newborn;   Persistent Occiput Posterior Position During Labor;   Complication of Delivery
Interventions: Other: Digital examination;   Other: Sonography evaluation
29 Active, not recruiting Cognitive Remediation in 22q11DS
Conditions: 22q11.2 Deletion Syndrome;   Velo-Cardio-Facial Syndrome
Interventions: Behavioral: Cognitive remediation program;   Behavioral: Small group social skills training
30 Terminated Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome
Conditions: Velo-cardio-facial Syndrome;   Psychosis
Interventions: Drug: Metyrosine;   Drug: Placebo
31 Recruiting Treatment of Chronic Myofascial Pain Syndrome Over Neck by Using Intravascular Laser Irradiation of Blood
Condition: Myofacial Pain Syndromes
Interventions: Device: Intravascular laser irradiation of blood (ILIB);   Device: Transcutaneous electrical nerve stimulation;   Other: Stretching exercise
32 Recruiting Study on Moebius Syndrome and Other Congenital Facial Weakness Disorders
Conditions: Brain Disorders;   Birth Defects;   Craniofacial Differences
Intervention:
33 Withdrawn CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap
Conditions: Cranial Nerve Diseases;   Facial Neuralgia;   Trigeminal Neuralgia;   Hemifacial Spasm
Interventions: Procedure: prophylactic spinal tap;   Procedure: no prophylactic spinal tap
34 Completed The Efficacy of Low-level Laser on Cervical Myofascial Pain Syndrome
Condition: Myofacial Pain Syndromes
Intervention: Other: low-level laser therapy
35 Unknown  The Effect of Low Level Laser Therapy (LLLT) in Myofacial Pain Syndrome
Condition: Myofacial Pain Syndrome
Interventions: Radiation: Low level laser therapy;   Radiation: Placebo group
36 Completed The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease
Conditions: Progressive Hemifacial Atrophy;   Romberg's Disease
Intervention: Procedure: Autologous Adipose Tissue derived MSCs Transplantation
37 Completed Impairments of Oral Language in Mobius Syndrome
Condition: Möbius Sequence
Intervention:
38 Completed Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain
Conditions: Facial Neuralgia;   Pain;   Trigeminal Neuralgia
Intervention: Drug: Dextromethorphan
39 Active, not recruiting
Has Results
Surfactant Positive Airway Pressure and Pulse Oximetry Trial
Conditions: Infant, Newborn, Diseases;   Other Preterm Infants;   Infant, Small for Gestational Age;   Premature Birth;   Bronchopulmonary Dysplasia;   Retinopathy of Prematurity
Interventions: Drug: Surfactant;   Device: Continuous Positive Airway Pressure (CPAP);   Drug: Supplemental oxygen with target saturation of 85 to 89%;   Drug: Supplemental oxygen with target saturation of 91 to 95%
40 Active, not recruiting Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Conditions: Infant, Newborn;   Hypoxia, Brain;   Hypoxia-Ischemia, Brain;   Encephalopathy, Hypoxic-Ischemic;   Hypoxic-Ischemic Encephalopathy;   Ischemic-Hypoxic Encephalopathy
Intervention: Procedure: Whole-body Cooling

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Indicates status has not been verified in more than two years